Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and now widely prescribed off-label for weight loss. Many patients wonder whether drowsiness or low energy accompanies GLP-1 treatment. The clinical evidence shows that sleepiness is not a documented side effect in major trials, though some people experience temporary fatigue during dose adjustments.
Is Drowsiness Listed as an Official Ozempic Side Effect?
Drowsiness does not appear on the FDA-approved prescribing information for Ozempic or in the clinical trial summaries. The most frequently reported side effects—nausea, vomiting, and diarrhea—occur in the gastrointestinal system, where GLP-1 receptors are densely concentrated. Fatigue and low energy are not among the top adverse events documented in semaglutide's pivotal trials.
What patients sometimes interpret as drowsiness may actually be other effects of GLP-1 therapy. Reduced appetite can lead to lower calorie intake, which naturally produces a sense of mild fatigue in some individuals. Nausea and digestive symptoms can also drain energy reserves, especially during the first two to three weeks of treatment initiation.
Why Do Some Patients Report Feeling Tired on GLP-1 Medications?
When patients do experience fatigue during semaglutide treatment, several mechanisms may contribute. Rapid weight loss triggers metabolic changes and shifts in hormone signaling, which can temporarily reduce energy availability. Additionally, GLP-1 receptors exist in the brain's energy-regulating centers, and activation of these pathways may subtly affect wakefulness in susceptible individuals.
Dehydration is an overlooked culprit. Nausea and vomiting lead to fluid loss, and inadequate hydration produces fatigue that resembles drowsiness. Ensuring consistent water intake and electrolyte balance often resolves this complaint within the first month. Dose escalation also matters—patients started at lower doses typically experience fewer adjustment-related energy dips than those jumping to higher doses rapidly.
How Individual Genetics Influence GLP-1 Response and Energy Levels
Not everyone responds identically to semaglutide. Genetic variation in GLP-1 receptor structure, appetite-regulating pathways, and metabolic genes shapes how aggressively your body reacts to the medication. Some people metabolize semaglutide more quickly or have heightened sensitivity to dose increases, potentially amplifying side effects including perceived low energy.
PlexusDx's Precision Peptide Genetic Test identifies variants in key genes—including GLP1R rs6923761 and FTO rs9939609—that influence how your body processes GLP-1 therapy and manages energy balance. Understanding these genetic predispositions allows your healthcare provider to anticipate potential fatigue risk and adjust your initial dose or titration schedule accordingly. This personalized approach reduces the likelihood of energy-draining side effects.
Managing Fatigue While Taking Compounded Semaglutide
If you experience low energy during semaglutide treatment, practical strategies can help. Start with a slower dose escalation—your medication does not need to increase every week. Allow your body two to three weeks to adjust at each dose level before advancing further. Staying hydrated, eating balanced meals despite reduced appetite, and maintaining light physical activity preserve energy reserves without triggering nausea.
PlexusDx offers compounded Semaglutide Injection starting at $149 per month, with dosing flexibility tailored to your tolerance. Unlike one-size-fits-all protocols, working with providers who understand GLP-1 pharmacology allows you to dial in the dose that maximizes weight loss while keeping side effects manageable. If fatigue persists beyond four weeks, switching to an alternative compound like oral semaglutide or exploring the Microdose GLP-1 Protocol may be appropriate—your dose may need to go up, but your price won't change.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Should I stop taking Ozempic if I feel drowsy?
Do not discontinue semaglutide without consulting your provider. Drowsiness is not a listed side effect and usually resolves within three to four weeks as your body adapts. If fatigue persists, your provider can reduce your dose, slow your escalation schedule, or explore alternative GLP-1 medications. PlexusDx supports flexible dosing adjustments to find your optimal balance.
Is fatigue on GLP-1 medication normal during the first month?
Some mild fatigue during initial weeks is not uncommon, but it is typically linked to nausea, reduced calorie intake, or dehydration rather than direct medication effects. Increasing water intake, eating small nutrient-dense meals, and allowing time for adjustment usually resolves this complaint by week three to four.
Can genetic testing predict whether I will feel tired on semaglutide?
PlexusDx's Precision Peptide Genetic Test examines 14 metabolic pathways and identifies variants in GLP-1 receptor genes, FTO, and MC4R that influence your medication response and fatigue risk. This $99 genetic profile, available after your first month of treatment, informs your provider about potential sensitivity to side effects and helps personalize your dose plan.
What is the difference between drowsiness and fatigue from weight loss?
Drowsiness is a specific symptom of central nervous system sedation, while fatigue from rapid weight loss is a general sense of low energy tied to calorie deficit and metabolic adjustment. GLP-1 medications rarely cause true drowsiness; most energy complaints reflect the body's transition to lower food intake and smaller body weight.
Does compounded semaglutide from PlexusDx cause different side effects than brand-name Ozempic?
Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as brand-name Ozempic and produces the same side effect profile. PlexusDx's compounded Semaglutide Injection at $149 per month offers equivalent safety and efficacy with greater dosing flexibility and no insurance requirements.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What You Need to Know About How Much Is Ozempic Per Month
Navigating Your Path to Wellness: A Detailed Guide on How to Test Your Ozempic® Pen